Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Chordate Medical Holding | CMH | Nov 22, 2024 | 20.40 | -1.92 |
Chosa Oncology AB | CHOSA | Nov 22, 2024 | 0.80 | 0.00 |
ChromoGenics | CHRO | Nov 22, 2024 | 9.78 | 0.00 |
Cibus Nordic Real Estate | CIBUS | Nov 22, 2024 | 170.55 | +2.28 |
Cinclus Pharma Holding AB | CINPHA | Nov 22, 2024 | 20.01 | +1.80 |
Cinis Fertilizer AB | CINIS | Nov 22, 2024 | 14.48 | +0.98 |
Cint Group | CINT | Nov 22, 2024 | 12.10 | +4.04 |
CirChem | CIRCHE | Nov 22, 2024 | 2.84 | -3.40 |
Circle Energy Sweden B | CIRCLEB | Nov 22, 2024 | 0.00 | 0.00 |
Clas Ohlson B | CLASB | Nov 22, 2024 | 191.60 | +2.19 |
Clavister Holding | CLAV | Nov 22, 2024 | 1.81 | -0.82 |
Clean Motion | CLEMO | Nov 22, 2024 | 0.34 | -4.47 |
Clemondo Group | CLEM | Nov 22, 2024 | 0.78 | +1.57 |
Climeon B | CLIMEB | Nov 22, 2024 | 0.33 | +2.50 |
Clinical Laserthermia Systems B | CLSB | Nov 22, 2024 | 4.50 | +19.05 |
Cloetta | CLAB | Nov 22, 2024 | 25.86 | +1.33 |
Cloudberry Clean Energy ASA | CLOUDO | Nov 22, 2024 | 12.00 | 0.00 |
CodeMill | CDMIL | Nov 22, 2024 | 14.80 | +2.07 |
Coegin Pharma | COEGIN | Nov 22, 2024 | 3.72 | -7.23 |
CoinShares International Limited | CS | Nov 22, 2024 | 87.90 | +5.90 |
Combigene | COMBI | Nov 22, 2024 | 2.56 | -0.78 |
Combinedx | CX | Nov 22, 2024 | 31.90 | +2.24 |
Comintelli | COMINT | Nov 22, 2024 | 3.04 | +0.66 |
Compodium | COMPDM | Nov 22, 2024 | 5.70 | 0.00 |
Concejo B | CNCJOB | Nov 22, 2024 | 41.10 | -1.20 |
Condo Nordic Holding AB | CONDO | Nov 22, 2024 | 1.50 | -4.46 |
Consensus B | CAMB | Nov 22, 2024 | 11.85 | -4.05 |
Coor Service Management Holding | COOR | Nov 22, 2024 | 32.96 | +0.30 |
Corem Property Group A | COREA | Nov 22, 2024 | 6.76 | +0.90 |
Corem Property Group B | COREB | Nov 22, 2024 | 6.76 | +2.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.